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Abstract
Since genetic abnormalities of human cancer are  
greatly geographically dependent, cultural and en -
vironmental backgrounds are thought to be closely  
related to the carcinogenic process. In the present 
study, eight human cell lines were established by  
culture from untreated carcinomas of the oral cancer, 
of which five were from primary oral squamous cell 
carcinomas (OSC), one from a mucoepidermoid  
carcinoma (MEC) and one each originating from  
metastatic OSC and MEC. All the studied tumor lines  
grew as monolayers, and showed: i) an epithelial 
origin by the presence of cytokeratin, and ii) 
tumorigenic potential in nude mice. Western blot 
analysis revealed i) over expression of EGFR in six  
of the cell lines ii) decreased expression of E- 
cadherin in six cell lines compared to normal human  
oral mucosa. A mutational analysis showed: point 
mutations of p53 at exon 7, with transversion, and at 
exon 8, with transition. These well-characterized  
human YD cell lines should serve as useful tools in  
the study of the molecular pathogenesis and bio -
logical characteristics of head and neck cancer cells, 
and in the future testing of new therapeutic reagents  
for oral cancer.
Keywords: carcinoma, mucoepideermoid; cadherins; 
carcinoma, squamous cell; cell line, tumor; mouth neo-
plasms; p53; receptor, epidermal growth factor
Introduction
There have been many studies on the establishment 
of cancer cell lines, they contribute to various basic 
research on cancer, as well as to diagnostic and 
therapeutic development. However, the establish-
ment of an oral cancer cell line is especially difficult 
from the primary site, and only a few successful 
attempts have been reported (Easty et al., 1981; Hu 
et al., 1984; Roa et al., 1985; Sacks et al., 1988; 
Tatke et al., 1995; Ji et al., 2001). Most previously 
established cell lines have been reported from lymph 
node metastatic foci, or transplanted tumors in nude 
mice. The reasons for the low success rate of esta-
blishing cell lines from primary tumors are con-
sidered to be due to bacterial contamination when 
the tumor tissue was resected and the low cellular 
activity of primary tumors compared to that of the 
metastatic tumors. However, cell lines derived from 
recurrent tumors, or metastasis, appear to be less 
differentiated, less well organized in culture, and 
demonstrate a morphological divergence displaying 
fewer desmosomes and tonofilaments, than cells in 
primary tumor lines (Easty et al., 1981). For these 
reasons, cell lines from primary tumors are required 
for understanding the biological characteristics of 
oral cancer. In addition, genetic abnormalities of 
human cancer are greatly geographically dependent, 
so cultural and environmental backgrounds are 
thought to be closely related to carcinogenic pro-
cess. In this report, 8 carcinoma cell lines, derived 
from six untreated primary, and two metastatic, 
tumors of the head and neck, were established and 
characterized, and designated as the YD cell lines. 
Of these cell lines, two originated from metastatic 
lymph nodes. The molecular characteristics, includ-
ing the frequency of ‘high-risk’ HPV infection and 
their proliferating activities, degree of differentiation, 
status of proto-oncogene EGFR, E-cadherin, and 
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mutation of tumor suppressor gene p53 were also 
studied. 
Materials and Methods
Establishment of cell lines
The surgical specimens were obtained from the op-
eration room suite, and transported to the labora-
tory in Dulbecco’s modified Eagle’s medium (DMEM; 
Gibco BRL, Grand island, NY), supplemented with 
10% fetal calf serum(FBS), 1 × 10-10 M cholera toxin, 
0.4 mg/ml hydrocortisone, 5 µg/ml insulin, 5 g/ml 
transferrin, and 2 ×10-11 M triiodothyronine. The can-
cer tissues obtained from the patients were treated 
with trypsin, and then the isolated cancer cells were 
grown with a feeder layer of mitomycin C-treated 
NIH 3T3 fibroblasts. The cells were fed with a 
mixture of DMEM and Ham’s nutrient mixture F12 
(Gibco BRL, Grand island, NY), at a 3:1 ratio, sup-
plemented with 10% FBS, 1 ×10-10 M cholera toxin, 
0.4 mg/ml hydrocortisone, 5 µg/ml insulin, 5 µg/ml 
transferrin, and 2 × 10-11 M triiodothyronine (T3). The 
cells were fed in an incubator at 37 C, with an 
atmosphere containing 5% CO2. The characteristics 
of the patients from whom these cell lines were 
established are given in Table 1. Histopathology 
showed that five cell lines were from primary SCC 
and one from a primary MEC. One each originated 
from metastatic SCC and MEC. 
Growth assay of the human OSC cell lines
Cells were plated at 1 × 104 cells/200 µl in each well 
of a 96 well plate. Every 24 h, 200 µl of the yellow 
MTT solution (0.05 mg/ml; Sigma Chemical Co., St. 
Louis, MO) was added to each well. The plates were 
covered with aluminum-foil, and then incubated at 
37 C, in 5% CO2 and 95% air, for 3 h. After incu-
bation, purple formazan salt crystals were formed. 
The untransformed MTT that remained in the su-
pernatant was removed by aspiration. The formed 
formazan crystals were dissolved by adding 150 µl 
of dimethylsulfoxide (DMSO; Sigma Chemical Co., 
St. Louis, MO). The plates were then placed into an 
ELISA reader (Benchmark Microplate Reader, Bio- 
Rad, Herclues, CA), and the optical density of the 
plates read at 570 nm to measure the maximal 
absorbance of the solubilized formazan product. For 
each time period, the mean optical density value 
was calculated. After establishing the growth curves, 
the population doubling times of the established cell 
lines were estimated from the exponential growth 
phase.
DNA profiles
Genomic DNA was extracted using the QIAamp 
DNA Mini kit (Qiagen, Hilden, Germany) according 
to the manufacturer's protocols. For DNA-finger 
printing analysis, DNA was amplified by PCR using 
short tandem repeats (STR) markers. Eight cell 
culture samples were genotyped using PowerPlex16 
(Promega, Medison, WI). Genotypes of 15 auto-
somal STRs (D3S1358, TH01, D21S11, D18S51, 
Penta E, D5S818, D13S317, D7S820, D16S539, 
CSF1PO, Penta D, vWA, D8S1179, TPOX and FGA) 
were determined in eight cell culture samples. Ad-
ditional genotypes of 5 X-STRs (GATA172D05, 
HPRTB, DXS8377, DXS101, HumARA) and 9 Y- 
STRs (DYS19, DYS385a/b, DYS389-I, DYS389-II, 
DYS390, DYS391 and DYS393) were determined in 
YD-10B by PCR (Shin et al., 2004). The PCR pro-
ducts were analyzed by capillary eletrophoresis us-
ing an ABI PRISM 310 Genetic Analyzer (Applied 
Biosystems, Foster City, CA).
In vivo tumorigenicity  
To investigate the in vivo tumorigenicity of the YD 
cell lines, 3-5 ×106 cells, mixed in DMEM, were 
injected subcutaneously into 4-6 week old male 
athymic nude mice (nu/nu; BALB/C), and the tumor 
formation was examined daily. When the mass had 
grown more than 1 cm, it was surgically removed, 
fixed in a 10% formalin solution, and paraffin-em-
bedded, for histological evaluation. 
Flow cytometric DNA measurement 
The cells were washed twice with PBS, resus-
pended in 500 µl of ice-cold ethanol and maintained 
at 4 C for at least 30 min. Prior to analysis, the cells 
were washed again with ice-cold PBS, resuspended 
in 500 µl of ice-cold PBS and treated with 0.1 mg/ml 
RNase A (Sigma Chemical Co., St. Louis, MO) at 
37 C for 30 min. Propidium iodide (PI; Sigma Che-
mical Co., St. Louis, MO), at a final concentration of 
50 µg/ml, was then added to the cell suspensions. 
After incubation on ice for 30 min, the cells were 
analyzed on a FACScan flow cytometer (Becton 
Dickinson, San Jose, CA) equipped with an Argon 
laser, at 488 nm. The percentages of cells in the 
G0-G1, S, and G2-M phases were estimated under 
the assumption of a Gaussian distribution. The 
multicycle mode FIT 2.0 cell cycle software (version 
2.0, Verity Software House Inc., Topsham, ME) was 
used to calculate the fraction of cells in the G0-G1 
(represented by the first peak on the histogram), S 
(between the first peak and second peak), and G2-M 
(the second peak) phases. The protocol was re-
peated in triplicate for each group, and the means 
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and standard deviations determined. 
Immunohistochemistry
For immunohistochemical staining, the paraffin-em-
bedded tissues from both surgical specimens and 
the culture tissues were used. After deparaffinization 
and rehydration, the endogenous peroxidase was 
blocked with 3% H2O2 in methanol, and the sections 
incubated with normal horse serum at room tem-
perature. Subsequently, a primary antibody, AE1/3 
(DAKO, Glostrup, Denmark) or Vimentin (DAKO, 
Glostrup, Denmark), was applied overnight at room 
temperature to detect cytokeratins. Slides were then 
incubated with biotin-labeled horse anti-mouse/anti- 
rabbit IgG (Vector Lab., Burlingame, CA) at room 
temperature for 30 min. Subsequently, the slides were 
incubated, with horseradish peroxidase streptavidin, 
at room temperature for 30 min. 3,3-diaminobenzi-
dine tetrachloride was used for visualization, and sli-
des were counterstained with Meyer’s hematoxylin. 
Immunofluorescence studies
Cells were seeded on eight-chambered cover glass-
es (Nunc Inc., Naperville, IL) at 2 × 104 cells/cham-
ber. Slides were fixed with acetone at -20°C for 10 
min, then incubated with primary mouse monoclonal 
antibodies directed either against vimentin at 1/100 
dilution (DAKO, Glostrup, Denmark) or cytokeratin at 
1/50 (DAKO, Glostrup, Denmark) or AE1/AE3 (DAKO, 
Glostrup, Denmark) for 60 min. After washing, Alexa 
594 donkey anti-sheep IgG conjugate (Molecular 
Probes Inc., Eugene, OR) were then added for 60 min 
and fixed again with ice-cold methanol for 10 min. All 
stained cells were stored under FluoroGuard anti-
fade mounting reagent (Bio-Rad, Herclues, CA) and 
viewed by fluorescence microscopy. 
Western blot analysis
Western blot analyses were performed as previous-
ly described (Yook et al., 1998) using anti-p53 
antibody (Pab 1801, Oncogene Sciences, Cambri-
dge, MA), anti mouse E-cadherin monoclonal anti-
body (clone 36, BD Bioscience, San Diego, CA) and 
anti-EGFR antibody (clone E-30, Biogenex Co, San 
Ramo, CA) from the cell lysate. All the lanes con-
tained equal amounts of protein, as determined by 
the Bradford method. After probing with each of the 
respective antibodies, the membranes were visua-
lized by enhanced chemiluminescence. 
Determination of HPV infection  
A polymerase chain reaction (PCR) method was 
used for the detection of human papillomavirus 
(HPV) genotypes using general primer sets (Mork et 
al., 2001). Two pairs of general primers were se-
lected from the conserved L1 open reading frame, 
with the use of these primers in the PCR enabling 
the detection of the HPV genotypes HPV-1a, -6, -8, 
-11, -13, -16, -18, -30, -31, -32 and -33. The L1 gen-
eral primers sequences were as follows: GP5 5’ 
TTTGTTACTGTGGTAGATAC, GP6 5’GAAAAATAA-
ACTGTAAATCA. The viral gene was amplified with 
DNA extracted from the OSC cell lines, using the L1 
general primers. Caski (HPV16), HeLa (HPV18), 
and HT3 cell lines were used as positive and 
negative controls, respectively.
Mutation Screening in p53 
DNA was extracted from the harvested culture cells 
using the phenol-chloroform method. PCR-SSCP 
analysis was performed to screen for p53 gene 
mutations in the OSC cell lines. The p53 exons 5-9 
were each amplified with 100ng genomic DNA, 20 
pmol of each primer, 2 umol dNTP, 10 mM Tris-HCl 
(pH 8.3), 50 mM KCl, 2.0 mM MgCl2 and 0.2 U Taq 
polymerase (Perkin-Elmer, Boston, MA). The condi-
tions used for PCR were: 30 cycles each of, den-
aturation for 30 seconds at 94 C, annealing for 30 
seconds at 60 C, and extension for 1 min at 72 C, in 
an automated thermal cycler (Perkin-Elmer, Boston, 
MA). The p53 primer sequences and PCR fragment 
sizes were as Table 1. SSCP was performed on 1 µl 
of PCR product diluted with 9 µl loading buffer (95% 
formamide, 0.25% bromophenol blue, 0.25% xyl-
encyanol). Samples were denatured at 95°C for 5 
min and immediately chilled on ice. Generally, 7 µl 
samples were applied to a 20% polyacrylamide gel 
and run at 100-150 V for 3-8 h. For optimal con-
ditions, electrophoresis was done at 4 , 14.5  and 
25 C using several PCR products in which muta-
tions on each exon were confirmed by sequencing. 
Then Gels were then stained using the DNA Silver 
Staining Kit (Bioneer, Korea).
DNA sequencing analysis
The PCR products were cloned, using the pGEM 
T-easy vector system (Promega, Madison, WI), and 
subsequently sequenced using an automated DNA 
sequencer (Autoassembler 1.0, Perkin Elmer, Bos-
ton, MA). The HT3 (codon 245 of exon 7: GGC→ 
GTC) and Caski cell lines (wild type p53 gene) were 
used as positive and negative controls, respectively.
Results
Establishment of YD cells
Eight carcinoma cell lines, from surgical specimens 
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of oral carcinoma specimens, designated as the YD 
cell lines, were established, of which 3 were from 
tongue (YD-8, -10B, and -15) and 2 from lower 
gingiva (YD-17 and -38). The YD-15M and YD-17M 
were originated from metastatic lymph nodes and 
YD-9 from buccal cheek. Histopathologically, all 
tumors, except two, were classified as SCC. The 
clinicopathological findings of 6 patients were sum-
marized in Table 1. Within the first 2 weeks of cul-
ture, the tumor cell clusters adhered to the surface of 
the dish, and gradually formed cell colonies. Once 
the tumor cells adapted to the in vitro conditions, 
they proceeded to grow rapidly. When the tumor 
cells had grown to semiconfluence in the dish, the 
first subculture was performed by transferring them 
to 25 cm2 flasks (Nunc). Thereafter, subcultures 
were performed periodically in a solution of 0.2% 
trypsin and 0.1% ethylenediaminetetraacetic acid. All 
of the cell lines have been maintained for more than 
2 yrs, passaged over 100 times, and continue to 
grow in a monolayer (Table 2).
DNA profiles
In order to confirm sample sources and assess the 
possibility of sample switching or contamination, eight 
cell culture samples were genotyped using Power-
Plex16. Genotypes of 15 autosomal STRs (D3S1358, 
TH01, D21S11, D18S51, Penta E, D5S818, D13S317, 
D7S820, D16S539, CSF1PO, Penta D, vWA, 
D8S1179, TPOX and FGA) were determined in eight 
cell culture samples. The genotyping results of eight 
cell culture samples are unique and unrelated (Table 
3A). Aadditional genotypes of 5 X-STRs (GATA-
172D05, HPRTB, DXS8377, DXS101, HumARA) and 
9 Y-STRs (DYS19, DYS385a/b, DYS389-I, DYS389- 
II, DYS390, DYS391 and DYS393) were determined 
in YD10-B which showed three banded allele pattern 
in vWA locus. At all 5 X-STR and 9 Y-STR loci, 
YD10-B samples displayed only one peak (Table 
3B). These results help exclude the possibility of 
cross contamination among the cell lines.
Table 1. Clinical and pathological findings of established oral cancer cell lines.
Cell line Age/Sex          Primary site Pathologic diagnosis Pathological nodal status
 YD-8 46/F Tongue SCC, MD
 YD-9 56/M Buccal cheek SCC, MD
 YD-10B 67/M Tongue SCC, MD
 YD-15
 YD-15M
39/M Tongue
Lymph node
MEC, HG
Metastatic    5/17   left I 2/7, II 3/10
 YD-17
 YD-17M
66/M Lower gingiva
Lymph node
SCC, PD
Metastatic
   6/41   Right I 1/10, II 5/15,
             III 0/12, Left 0/4
 YD-38 67/M Lower gingiva SCC, MD
SCC, squamous cell carcinoma; MEC, mucoepidermoid carcinoma; MD, moderately differentiated; PD, poorly differentiated; HG, high 
grade
Table 2. Properties of established oral cancer cell lines.
   Cell line Doublingtime
Growth
characteristics
Prior
chemotherapy Passage
Cell cycle distribution
TumourigenicityG0/G1
(%)
S
(%)
G2/M
(%) DNA index
YD-8  29.3 Adherent None >100 39.5 10.9 49.6 1.92 0/5
YD-9  33.4 Adherent None >142 59.2 22.5 18.3 1.91 0/5
YD-10B  25.3 Adherent None >137 42.8 19.0 38.2 1.91 5/5
YD-15
YD-15M
 19.8
 20.8
Adherent
Adherent
None 
None
>198
>226
47.0
35.5
16.6
20.3
36.4
44.2
1.84
1.91
0/5
1/5
YD-17
YD-17M
 29.2
 19.6
Adherent
Adherent
None 
None
>196
>100
51.9
51.5
16.2
12.5
31.9
35.9
1.91
1.86
0/5
0/5
YD-38  21.6 Adherent None >185 52.1 26.3 21.6 1.92 0/5
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Morphologic and biologic characteristics
Figure 1 shows the photomicrographs of the YD 
cells. All cells adhered tightly to the flask in a mon-
olayer sheet. The appearance of the YD-8, YD-15, 
YD-15M, YD-17, YD-17M, and YD-38 cells were 
polygonal, whereas the YD-9 cells were slightly 
elongated and the YD-10B cells were round to oval 
shaped tumor cells. All the YD cell lines grew as 
monolayers, and their population doubling time rang-
ed from 19.8 to 33.4 h. The average doubling time of 
the established carcinoma cell lines was 24.9 h, and 
the YD-15, YD-15M, YD-17M cell lines, derived from 
metastatic lymph nodes, showed faster doubling 
times (Table 2). A total of 1 × 105 YD cells, after 
more than 100th passages, were analyzed by flow 
cytometry, and the results are summarized in Table 
2. All of the cell lines were aneuploid, with a DNA 
index of around 1.9. 
Analysis of epithelial markers and epithelial
junction molecules
To detect cytokeratin expression in the primary and 
metastatic tumors of the YD cell lines, immunohisto-
chemical staining was performed for AE1/3, and 
cytokeratin was expressed in the cytoplasm of all YD 
cell lines (Figure 2). In postembryonic cells, cytoker-
atins are the epithelial counterpart of vimentin; there-
fore, we also examined the expession of vimentin. 
Double immunostaining of cells revealed that all of 
the YD cells expressed only cytokeratin (Figure 2). 
Another important characteristic that distinguishes 
epithelial from mesenchymal cells is the cell junc-
tional complexes formed by homotypic cell adhesion 
molecules, principally the E-cadherin. Western blot 
analysis was performed to measure the level of 
E-cadherin in extract from all of the YD cell lines. 
E-cadherin was expressed in all YD cells except, but 
the expression was decreased compare to normal 
human oral mucosa (Figure 3A). 
Table 3A. Observed alleles of the 15 autosomal STR markers in the YD cell lines.
   Locus  YD-8  YD-9   YD-10B     YD-15 YD-15M    YD-17  YD-17M YD-38
D3S1358 15-16 15-16 17-17 15-15 15-15 14-15 14-15 16-16
TH01   7-9   6   6-9   6-9   6-9 9.3-9.3 9.3-9.3   6-9
D21S11 29-30 30 30-32 30-31.2 30-31.2 28-31 28-31 30-31
D18S51 15-16 13 14-14 14-14 14-14 14-16 14-16 14-14
Penta E 12-15 15-17   5-8 14-19 14-19   5-12   5-12 12-19
D5S818 12-12 10-12 11-13 12-12 12-12 12-12 12-12 14-14
D13S317   8-10 13   9-9 11-12 11-12   8-8   8-8   8-8
D7S820 10-13 11-12 11-11 12-13 12-13 10-11 10-11 10-11
D16S539   9-11 12-13 10-11   9-12   9-12   9-12   9-12 12-13
CSF1PO 10-10 10-12 12-13 10-12 10-12 10-12 10-12 12-12
Penta D 13-13   9   8-9   9-9   9-9   9-13   9-13   8-12
vWA 14-17 14-19 18-19-20 15-15 15-15 15-16 15-16 14-17
D8S1179 13-16 11-13 11-11 15-15 15-15 13-15 13-15 14-14
TPOX   8-11   8-9   8-8   9-9   9-9   8-11   8-11   8-8
FGA 24-24 25 23-23 23-23 23-23 24-24 24-24 22-25
Table 3B. Observed alleles of the five X- and nine Y-linked 
STR markers in the YD-10B cell line.
             Locus           Observed alleles
GATA172 10
HPRTB 12
DXS8377 57
DXS101 22
HumARA 23
DYS392 11
DYS389I 13
DYS19 15
DYS389II 29
DYS393 13
DYS391 10
DYS390 24
DYS385a/b 12-14
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Histological observation of transplanted tumors
To determine whether the YD cell lines were tumor-
igenic, 3-5 × 106 cells were subcutaneously injected 
into nude mice(five mice/cell line). As shown in Table 
2, the YD-10B and -15M developed tumors. The 
incidence of transplantability by subcutaneous ino-
Figure 1. Microscopic features of established oral cancer cell lines. (A) YD-8 showing a sheet of polygonal cells scattered with dyskeratotic cells. (B) 
YD-9 showing slightly elliptical appearance of tumor cells. (C) YD-10B showing round to oval shaped tumor cells. (D) YD-15 showing relatively round, 
ovoid or angular shaped tumor cells. (E) YD-15M showing a sheet of oval shaped tumor cells. (F) YD-17 showing a sheet of polygonal cells. (G) 
YD-17M showing a sheet of polygonal cells similar to YD-17. (H) YD-38 showing a sheet of polygonal cells with irregular border.
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culation of cancer cells was 1/5 in YD-15M and 5/5 
in YD-10B. Transplanted tumors were well circum-
scribed by surrounding fibrous tissue. No invasive 
growth was evident. The central portion of the trans-
planted tumors underwent severe ischemic necrosis. 
Transplanted tumor of YD-10B showed well-differen-
tiated SCC and had similar morphology to their 
respective original tumor of the tongue. However, a 
transplanted of YD-15M showed a poorly differen-
tiated SCC, this devoid of mucous cells or glandular 
differentiation (Figure 4). 
Expression of proto-oncogenes EGFR
Figure 3(B) shows the expressions of EGFR in newly 
established YD cell lines, with most overexpressing 
EGFR, with the exception of the YD-8, compared to 
normal keratinocytes and gingival fibroblasts. The 
YD-8 cell line harbored a lower amount of the EGFR 
expression than normal keratinocytes. 
Figure 2. Expression of differentia-
tion markers on the established can-
cer cell lines. Immunostaining for cy-
tokeratins using the monoclonal anti-
body cocktail AE1/AE3 was per-
formed. All YD cells showed AE1/3 
immunoreactivity. AE1/3 is expres-
sed in the cytoplasms of YD cell 
lines.
Figure 3. Expression of E-cadherin, EGFR, and p53 
in the established oral cancer YD cell lines.(A) E-cad-
herin expression of established oral cancer cell lines. 
(B) EGFR expression of established oral cancer cell 
lines. Most of the cancer cell lines overexpressed 
EGFR except YD-8. (C) p53 expression of established 
oral cancer cell lines. (D) β-actin protein served as an 
internal control. A431, positive control; NK, normal 
keratinocytes, GF, gingival fibroblasts.
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Mutational analysis in tumor suppressor genes p53
The presence of mutation of the p53 gene was exa-
mined by performing PCR-SSCP and by subsequent 
DNA sequencing of exons 4-9 of the p53 gene in the 
YD cell lines (Figure 5). Exon 7 showed point muta-
tion in three cell lines (YD-10B, YD-15, and YD-15M) 
and exon 8 in one, the YD-8. Both the YD-15 and 
YD-15M cell lines revealed the same point mutation 
at codon 258 of exon 7, that is, the GAA sequence 
was changed to GCA, which resulted in an amino 
acid mutation of Glu to Ala. The YD-8 cell line also 
showed a point mutation at codon 273 of exon 8, the 
GGT sequence was changed to CAT, which was 
changed from Arg to His. The YD-10B cell line 
showed a frame shift mutation at codon 236 of exon 
7, the TAC sequence was changed to TAA (Table 4). 
The level of p53 protein was analyzed by Western 
blot analysis. p53 protein was detected in the YD-8, 
YD-9, YD-15, and YD-15M (Figure 3C).
Determination of human papillomavirus (HPV)
infection in the human OSC cell lines
‘High-risk’ HPVs have been found in OSC, and a 
large number of studies have examined the rela-
tionship between HPV infection and SCC of the oral 
region. The YD cell lines were examined for the 
presence of HPV DNA by PCR amplification, and all 
proved to be free of HPV DNA (Figure 6).
Discussion
Human cancer cell lines in cultures are widely used 
in cancer research, where experiments cannot be 
performed using tissue from in vivo specimens and 
are important tools in understanding the biology of 
human cancers. A number of tumor cell lines have 
been established from human cancers obtained from 
primary or xenografted tumors (Thomson et al., 
1995; Ku et al., 2002). However, the establishment 
of SCC cell lines is considered to be difficult, and low 
success rates have been reported. For example, 
three esophageal carcinoma cell lines were establi-
shed by one group using 100 specimens (Hu et al., 
1984), and another group reported the establishment 
of two head and neck lines from more than 100 
specimens (Hauser et al., 1985). In 1981, two teams 
reported the development of head and neck SCC 
cell lines. With explants outgrowth techniques, a se-
ries of cell lines, designated HN1-HN10, were de-
rived from patients who had received radiotherapy, 
with or without chemotherapy (Easty et al., 1981). 
The second group used feeder layer techniques, 
similar to the methods employed by us, to establish 
two carcinoma cell lines of the epidermis and four of 
the tongue (Rheinwald et al., 1981). One patient with 
a tongue carcinoma had received prior radiation and 
chemotherapy, but three had not been treated. Using 
inactivated 3T3 mouse cell feeder layers developed 
these cell lines. Another research group established 
Figure 4. In vivo tumorigenecity in 
athymic nude mice. (A) Subcutan-
eous tumor formation in nude mice. 
The incidence of transplantability by 
subcutaneous inoculation of cancer 
cells was 1/5 in YD-15M and 5/5 in 
YD-10B. (B) Low magnifications (40
×) of histopathologic findings of tu-
mor of YD-10B in athymic nude mice 
showing a well differentiated squ-
amous cell carcinoma. (C) High pow-
er of the tumor (100 ×) showing cel-
lular pleomorphism and many mitotic 
figures. (D) A transplanted of YD- 
15M showed a poorly differentiated 
SCC, this devoid of mucous cells or 
glandular differentiation.
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four new HNSCC cell lines, using outgrowth techni-
ques, on tumors from patients who had received 
radiotherapy (Rupniak et al., 1985). Thus, while the 
number of available HNSCC cell lines expands, 
there are still limited numbers in existence, and even 
fewer that are useful as models for the development 
and progression of this important type of tumor. Most 
of these cell lines were isolated more than 10 yrs 
ago, however, and have been passaged many times 
in vitro in uncontrolled growth conditions. Therefore, 
they could have lost their phenotypic heterogeneity. 
The use of carcinoma cell lines with a low passage 
number and newly established cell lines would solve 
this problem. Tumors are well known to be hetero-
geneous in a number of their parameters (Dexter et 
al., 1982). Radiotherapy and chemotherapy, by eli-
minating sensitive cell populations, may alter a tu-
mor’s in vivo progression and cell heterogeneity 
(Nicolson et al., 1984). Therefore, our interest was in 
establishing cell lines from tumors from Korean oral 
cancers, as the development of human cancers, in-
cluding oral cancers, are known to be closely related 
to racial and cultural variables, and reference data 
from different cell lines are required from different 
Figure 5. p53 mutations in the es-
tablished cancer cell lines. (A) PCR- 
SSCP analysis with 20 % acrylamide 
gel showing band shift of exon 7 in 
YD-10B, YD-15, and YD-15M. (B) 
Sequencing results showing point 
mutations in YD-8, YD-10B, YD-15, 
and YD-15M.
Table 4. Mutational analysis of p53 in YD cell lines.
Gene Cell line Mutated codon(exon number)
Base change
or deletion
     Amino acid
        change
P53
 YD-8 273(8) CGT → CAT Arg → His
 YD-10B 236(7) TAC → TAA Tyr → stop codon
 YD-15 258(7) GAA → GCA Glu → Ala
 YD-15M 258(7) GAA → GCA Glu → Ala
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ethnic groups for untreated oral cancers as these 
are most likely to represent the original primary tumor. 
The eight new YD cell lines described here were 
established from untreated primary tumors. The suc-
cess rate was at 18%. It is our belief that such cell 
lines are more likely to represent the initial tumor than 
lines derived from therapeutically treated patients.
  OSC is the most common malignant neoplasm of 
the oral mucosa, accounting for more than 90% of all 
intraoral malignant tumors. Tobacco and alcohol use, 
viral infections, nutritional deficiency, and dietary 
habits have all been implicated in the etiology of 
head and neck cancer (Ahrendt et al., 2000; Bala-
ram et al., 2002). Although the etiology of an OSC is 
unclear, substantial evidence indicates that the 
activation of proto-oncogenes, and the inactivation of 
tumor suppressor genes, underlies the disease de-
velopment. To understand the molecular mecha-
nisms underlying the development of OSC cell lines, 
the frequency of HPV infection and status of the 
proto-oncogene (EGFR), and tumor suppressors 
(p53) were investigated.
  The HPV infection is also closely linked to benign 
and malignant oral lesions (Mork et al., 2001). The 
involvement of the HPV infection in the development 
of oral cancer becomes evident from the frequent 
detection of ‘high-risk’ HPV DNA in OSC tissues and 
cell lines. Previous studies have reported the pre-
sence of HPV types 16 and 18 in oropharyngeal 
cancers specifically tonsillar cancers. In our study, 
we found that HPV16 presence was not significantly 
associated with our YD cell lines and tissues tested. 
Previous studies have similarly reported, HPV DNA 
from Korean fresh tumor tissue subjected to PCR 
amplification of the L1 or E7 viral region was unde-
tectabe. Our findings suggest oral cancer was strong-
ly associated with HPV16 presence in the Western but 
not Korean.
  In our study, the p53 gene was point mutated in 
33% and frame shift mutated in 11% of the YD cell 
lines and all of these mutations occurred in highly 
conserved regions. The majority of p53 mutations 
occur in the central conserved part of the protein or 
‘core domain’ (residues 102-292), which is respon-
sible for sequence specific DNA binding. In general, 
these mutations are of the missense type and lead 
to loss of DNA binding, which is believed to be 
critical for the biological activity of p53. In our study, 
codon 258 showed point mutation in two cell lines 
(YD-15 and YD-15M) and codon 273 in one, the YD- 
8. The YD-10B cell line showed a frame shift mu-
tation at codon 236. These results raise questions 
over the functional significance of p53 gene mu-
tations and this issue was investigated by analyzing 
p53 protein levels. Since the half-life of wild type p53 
protein is several minutes, p53 protein levels in 
normal cells are relatively very low and generally 
undetectable by immunoblotting. However, abnormal 
p53 protein can be easily detected by immuno-
blotting because of the prolongation of its half-life. 
As shown in Figure 3, the over expression of p53 
protein was found in all the p53-mutated YD cell 
lines, with the exception of one case with a non-
sense mutation. However, one of the YD cell lines, 
not showing the p53 gene mutation, also positively 
expressed the p53 protein. There are several pos-
sible mechanisms, other than a point mutation, 
which can result in the over expression of the p53 
protein (Yook et al., 1998; Wong et al., 2002). 
Genetic alternation in another region of the exon, 
such as the promoter or intron of the p53 gene, 
could result in a high expression of the wild type 
p53. However, 90% of mutations are clustered 
between exons 5 and 8 in four conserved regions of 
the p53 gene. Another possibility is the binding of 
the wild-type p53 protein to other proteins, such as 
MDM2 or E6 viral oncoprotein, stabilizes and inac-
tivates as a result of the over expression (Barenes et 
al., 1992; Momand et al., 1992; Cho et al., 2002; 
Seo et al., 2004). The results of PCR-SSCP followed 
by direct DNA sequencing and immunoblotting de-
monstrated p53 gene mutations associated with 
abnormal accumulation of p53 protein in OSC cell 
lines. Since p53 is closely related to various proteins 
regulating the cell cycle, abnormal p53 function may 
cause accelerated cell proliferation leading to mul-
ticentric tumorgenesis and malignant tumor. How-
ever, 60% of multiple and malignant cases showed 
no mutations of the p53 gene. This suggests that 
p53 gene mutation is not a necessity for the de-
velopment of multiple and malignant OSC.
  To understand the possible role of proto-oncogenes 
in the development of the YD cell lines, the ex-
pression of EGFR was examined. Several studies 
Figure 6. Detection of HPV DNA in the established cancer 
cellular lines. PCR amplification of tumor cell DNA show-
ing no HPV DNA in established cancer cell lines. Caski 
and HeLa were used as positive control for HPV infection.
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have demonstrated the over expression of EGFR in 
primary oral cancers and OSC cell lines (Frank et 
al., 1991; Satini et al., 1991; Shirasuna et al., 1991). 
Our results showed the over expression of EGFR in 
newly established YD cell lines. Interestingly, YD-8 
cell line showed much lower expression of EGFR 
compared to normal oral keratinocyte. Ludes-Mayers 
et al., (1996) reported that p53 mutations might 
directly contribute to the gain of some growth pro-
moting functions (gain of function phenotype), rather 
than represent the mere loss of the wild-type p53 
function. Mutant p53 proteins are usually present at 
high levels in cancer cells, which may lead to the 
strong and continuous activation of expression in 
growth related genes, with oncogenic consequen-
ces. This observation gives rise to the possibility, 
that in cancer cells expressing high levels of mutant 
p53, the mutant protein may transactivate the pro-
moter of the gene expressing human EGFR, result-
ing in more aggressive growth of these cells. The 
significance of the wild type p53-mediated transacti-
vation of the EGFR promoter remains unclear. In our 
study that the YD-8 of p53 mutant cancer cells ex-
press high levels of mutant p53 but not EGFR is not 
likely to occur in p53 mutated cell line. Although our 
interest was in finding whether the EGFR was am-
plified dependently or independently of the mutant 
p53 protein, the details at present are indistinct.
  Expression of the cell-cell adhesion molecule E- 
cadherin correlates with epithelial differentiation and 
and loss of E-cadherin may induce invasive growth 
of cancer cells (Batlle et al., 2000; Ackland et al., 
2003). Our results showed that all YD cell line ex-
pressed E-cadherin. Morphological features of al-
most all cell lines tested showed polygonal, ovoid or 
elongated shaped cells representing epithelial differ-
entiated, evidenced by cytokeratin expression. 
  In summary, eight newly established human OSC 
cell lines, with the histopathology of their primary 
tumors, in vitro growth characteristics, epithelial ori-
gin, and in vivo tumorigenicity have been reported. 
In addition, the status of their HPV infection, proto- 
oncogene (EGFR), tumor suppressor gene (p53), 
and E-cadherin are also reported. These eight cell 
lines will provide new permanent culture models for 
the study of the pathogenic mechanism, investi-
gation their biological behavior, and to test new 
therapeutic reagents for oral cancer in the future. 
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